What will happen to the Ε mΔling Chapel? Itβs just a matter of money
The planned demolition of the historic Ε mΔling Chapel at the Children's Clinical University Hospital has sparked public outrage and raised questions about its preservation amidst prevalent regulatory challenges.
Do mystical experiences with psychedelics really bring benefits for mental health?
The article discusses the potential mental health benefits of mystical experiences induced by psychedelics like psilocybin and LSD, supported by clinical studies suggesting these experiences can improve conditions such as depression and anxiety.
Professor who reportedly paused UK puberty blockers trial removed over bias claims
Prof Jacob George has been removed from his role in the UK trial of puberty blockers amid bias allegations linked to his past social media posts.
The phenomenon of therians: less alarm and more real connection
The phenomenon of 'therians' involves young people identifying partially with non-human animals and has gained attention due to social media, but is not seen as a clinical disorder.
New drug against HIV may revolutionize treatment in the elderly
A new daily single-dose pill for HIV treatment, BIC/LEN, has shown promise in clinical trials, simplifying the lives of long-term HIV patients.
NCDMB unveils medical lab at Bayelsa varsity
A new Clinical Skills and Simulation Laboratory was inaugurated at Bayelsa Medical University to enhance medical education and local healthcare capabilities.
Rare Diseases: Significant Delays in Accessing Treatments for Patients in Greece
This article discusses the challenges faced by patients with rare diseases in Greece regarding access to treatments, emphasizing the impact of the COVID-19 pandemic on healthcare and clinical research.
Debate on polylaminin could clarify the boundaries of science
The discussion surrounding the Brazilian clinical research on polylaminin highlights both the potential benefits and limitations of the molecule, which may offer hope in treating severe spinal injuries.
Use of polylaminin is monitored in real time by society: 'Like a Big Brother', says researcher
Research on polylaminin, a substance being studied as a possible treatment for spinal cord injuries, is closely monitored by society, according to lead researcher Tatiana Sampaio.
Eastern Hospital receives another 34 severely injured soldiers from Ukraine
An additional 34 severely injured Ukrainian soldiers have been admitted to the Eastern Clinical University Hospital in Riga, Latvia, bringing the total to 816 since the war began.
Brazil creates first rule for AI in medicine: diagnosis cannot be automatic and patients may refuse use
Brazil's Federal Medical Council has established its first specific guideline governing the use of artificial intelligence in medical practice, emphasizing that AI must serve as a supportive tool rather than a replacement for human clinical judgment.
South Africa: "Ethics, Trust, and the Future of Pediatric HIV Cure"
A recent webinar addressed the ethical and scientific considerations in pediatric HIV cure research, highlighting the role of people living with HIV in this field.
New HIV drug could revolutionize treatment for the elderly
A new once-daily HIV drug could simplify treatment for elderly patients who have been managing the virus for decades.
What do we know about Mazdutide, the medication with which you can lose up to 20 kilograms in a year?
Mazdutide, a weight-loss medication, shows significant weight loss results in a Chinese study, with participants losing an average of nearly 19% of their body weight over 48 weeks.
The first clinical trial to 'reprogram' human aging is launched
The first human clinical trial aimed at reversing aging processes has begun, announced by Dr. David Sinclair at the World Government Summit.
Fiocruz starts studies with therapy for Spinal Muscular Atrophy; costs may reach 25% of current value
Fiocruz has initiated its first clinical study for a gene therapy aimed at treating severe Spinal Muscular Atrophy (SMA) in Brazil, potentially reducing treatment costs significantly.
UPA Dr. Thelmo reduces waiting times for exams by up to 75% with new laboratory
The UPA Dr. Thelmo in JacareΓ has installed a new clinical analysis laboratory that drastically reduces waiting times for exam results.
Research on new medications, such as polylaminin, must follow strict international rules
The development of new medications, including polylaminin, requires adherence to strict international guidelines, particularly in clinical trials that involve control groups to assess efficacy and safety.
New GLP1 pill helps patients lose up to 8% of body weight, trial shows
A new daily pill called orforglipron shows promise in helping patients lose weight, according to a clinical trial, potentially offering a non-injection alternative to existing GLP-1 medications.
Polylaminin is promising, but must overcome clinical trials
Polylaminin shows promise as a potential treatment for severe spinal injuries but faces significant challenges in clinical testing.
How long will it take for us to know the effectiveness of polylaminin? Understand the substance in 16 topics
Polylaminin has generated significant attention on social media due to its association with reports of patient recovery, but experts urge caution due to a lack of robust clinical evidence supporting its efficacy and safety.
A single daily pill against HIV to replace more complex treatments in patients with resistances
New research suggests that a single daily pill combining two medications may effectively substitute more complex HIV treatments.
ANNA-KAISA OIDERMAA β© How lonely people can become a united state
A clinical psychologist discusses the growing issue of loneliness in Estonia, particularly among young people, as highlighted by President Alar Karis in his anniversary speech.
We will survive, but we are often exhausted. This is not often talked about in the office, says the coordinator of a survey on the lives of cancer patients
The article discusses the psychological and emotional challenges faced by cancer patients, particularly those undergoing the 'watch and wait' treatment approach, highlighting their struggle to balance everyday life and the lack of awareness regarding clinical trial opportunities.
The increase in clinical trials in the EU will bring an additional 4 billion euros to healthcare systems
The European Commission and related organizations are striving to attract more clinical trials, which could generate additional funding and job creation in the healthcare sector.
Ayahuasca psychedelic DMT shows promise as depression therapy
A study indicates that DMT, a key component of the psychedelic ayahuasca, may effectively reduce depression symptoms in patients.
"They wanted me to leave the country." Another well-known doctor described what happened in IKEM
A prominent Czech doctor recently reported troubling events at the Institute for Clinical and Experimental Medicine (IKEM), hinting at external pressures.
Polylaminin: How the studies were conducted, what are the results so far, and what does Anvisa say? Understand
A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.
The government facilitates the financing of the construction project of the A2 building of StradiΕΕ‘ hospital
The Latvian government has decided to allow the second phase of the A2 building project at Paula StradiΕΕ‘ Clinical University Hospital to exceed 90% of its funding through advance and interim payments.
Novo on the way with a new weight loss drug
Novo Nordisk has released data from a study on a weight loss drug developed in collaboration with Chinese company United Biotechnology, showing significant weight loss among participants.
Expanded opportunities for hearing examinations at the Children's Hospital
The Children's Clinical University Hospital in Latvia has enhanced its hearing examination services for children starting from as young as three months old.
Erotic Fatigue: Why Sexual Desire Is No Longer Enough (Even If You Want It) and How to Recover It
This article discusses the phenomenon of erotic fatigue, where individuals experience a desire for sex but struggle to act on it, exploring psychological and clinical perspectives on the issue.
Don't treat polylaminin as if it were the national team
The article discusses the recent hype surrounding polylaminin, a substance believed to regenerate spinal cord injuries, and its political implications in Brazil.
Novo Nordisk's shares plummet more than 16% after results of new drug
Novo Nordisk's shares sharply declined following disappointing clinical trial results of its new weight-loss drug, CagriSema, which underperformed compared to a competitor's product.
Uganda: JCRC Launches Shs15bn Drive to Build Uganda's First Bone Marrow Transplant Centre
The Joint Clinical Research Centre has initiated a Shs15 billion fundraising campaign to establish Uganda's first bone marrow transplant center to improve treatment for sickle cell disease and blood disorders.
Neurologists alert to lack of evidence on the action of poly-L-lysine in spinal cord injury
Brazilian neurologists warn about insufficient scientific evidence supporting the use of poly-L-lysine for treating spinal cord injuries in humans.
Colon Cancer: A Study Confirmed That Early Detection Reduces Cases of Severity
A clinical study shows that screening for colorectal cancer significantly aids early detection and reduces advanced cases.
Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is branded βobsoleteβ
Novo Nordisk's new weight-loss drug, CagriSema, has been deemed 'obsolete' after disappointing clinical trials, leading to a significant drop in the company's shares.
Novo Nordisk: 15% Drop in Stock - Why the Clinical Trial of CagriSema Was Disappointing
Novo Nordisk's stock plummeted 15% after its new drug CagriSema failed to meet key weight-loss targets in a clinical trial compared to Eli Lilly's tirzepatide.
βDisability-Friendly Hospitalsβ to Be Operated Nationwide in Eight Locations by 2030
The South Korean government plans to designate and operate eight βDisability-Friendly Hospitalsβ by 2030 to support the entire clinical process for people with disabilities.
Men addicted to sex, pornography, and compulsive masturbation β this study is for you
A groundbreaking clinical trial in Poland is set to examine the pharmacological treatment of compulsive sexual behaviors, particularly focusing on compulsive masturbation.
Converted to Catholicism / I was Evangelical, but I prayed the rosary, read mystics, and went on pilgrimages. I lived a double life
Jozef ΔanovskΓ½, a clinical psychologist in Slovakia, recounts his spiritual journey from being a Presbyterian to converting to Catholicism, highlighting his inner conflicts and the emotional challenges he faced.
Scientific societies call for caution and precision in the debate over poly-laminin
Scientific societies in Brazil urge caution in the discussion surrounding poly-laminin, a protein under investigation for spinal cord injury regeneration, emphasizing the importance of distinguishing experimental research from established clinical application.
Consciousness survives for hours after clinical death and may be connected to the Universe, new studies suggest
New studies suggest that human consciousness may persist for hours after clinical death, leading to intriguing questions about the nature of consciousness and its possible connection to the Universe.
Ovarian cancer could be detected at earliest stage with 'medical tampon'
A new trial is investigating the use of a specialized tampon for the early detection of ovarian cancer by identifying biological markers in vaginal fluid.
Trial into puberty blockers for children paused over 'wellbeing concerns'
A clinical trial of puberty blockers for children has been paused due to new concerns regarding the wellbeing of participants, prompted by advocacy from JK Rowling and others.
Santos confirms two cases of mpox; see symptoms and numbers in SP
The city of Santos, Brazil, has confirmed two cases of mpox, with affected patients showing good clinical recovery and receiving discharge from the hospital.
UK clinical trial into puberty blockers paused after medicines regulator raises concerns
A UK clinical trial on puberty blockers for children has been paused following concerns from the Medicines and Healthcare products Regulatory Agency about potential long-term biological harms.
Problem with obesity drugs: patients lose too much weight, get scared, and stop taking them
A new obesity drug trial reveals significant weight loss but raises concerns as patients abandon the study due to fears of losing too much weight.
Promising drug compound attacks fat from genetic roots
A new oral drug compound, TLC-2716, shows promise in significantly reducing blood fat levels linked to fatal heart diseases.